Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-10-049914
Filing Date
2010-09-17
Accepted
2010-09-17 16:08:06
Documents
1
Group Members
BLACKWELL PARTNERS LLCDUMAC, LLCEMPLOYEES' RETIREMENT PLAN OF DUKE UNIVERSITYGOTHIC HSPTHE DUKE ENDOWMENT

Document Format Files

Seq Description Document Type Size
1 v196951_sc13ga.htm SC 13G/A 299190
  Complete submission text file 0001144204-10-049914.txt   301240
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 101078356
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DUMAC, LLC, 406 BLACKWELL STREET SUITE 300 DURHAM NC 27701
Business Address DUKE UNIVERSITY DURHAM NC 27708 (919) 668-9995
Duke University (Filed by) CIK: 0001439873 (see all company filings)

EIN.: 560532129 | State of Incorp.: NC | Fiscal Year End: 0630
Type: SC 13G/A